TOFAGRAM OINTMENT contains tofacitinib, a Janus kinase (JAK) inhibitor that helps suppress inflammatory immune responses in the skin. The medication targets immune signaling pathways associated with autoimmune damage to hair follicles and chronic skin inflammation.
Recommended for:
Tofacitinib is actively studied in dermatology as a promising therapy for alopecia areata and other autoimmune skin conditions. Clinical studies have shown that JAK inhibitors may stimulate hair regrowth in some patients with alopecia. Research is also ongoing regarding the effectiveness of topical tofacitinib for vitiligo and chronic inflammatory dermatoses. Interest in topical formulations is associated with the potential for reduced systemic exposure while maintaining therapeutic benefits.
The medication is indicated for alopecia areata, autoimmune skin disorders, and inflammatory dermatological conditions. Tofacitinib helps reduce inflammatory activity, decreases immune-mediated tissue damage, and supports restoration of skin and hair follicle health.
Apply a thin layer of the ointment to the affected skin areas as directed by a physician. Frequency and duration of treatment depend on the diagnosis and severity of symptoms. Avoid contact with eyes and mucous membranes. Wash hands after application.
Contraindications:
Side effects:
